Make MDS drugs available, says support group

A fifth of people with MDS (blood cancer) die prematurely because the NHS won’t fund new life-extending drugs, the UK MDS Patient Support Group...

Pharma-diagnostics collaborations to increase, says PwC

The growth of personalised medicine will increase the number of alliances between diagnostic and pharmaceutical businesses, says a new PricewaterhouseCoopers (PwC) report. The report,...

New global leadership team for Merck

Merck has named the senior management team that will lead the new company following the merger of Merck and Schering-Plough. Richard Clark was named...

Benefit of kidney cancer drugs ‘still too small’

NICE has decided not to recommend Avastin (bevacizumab), Nexavar (sorafenib) and Torisel (temsirolimus) for kidney cancer. Although NICE acknowledged that the drugs extend life...

Conditional recommendation issued for Erbitux in mCRC

NICE has issued final guidance recommending Erbitux (cetuximab) as a first line treatment for metastatic colorectal cancer (mCRC). The guidance recommends cetuximab in combination...

Philips launches full-face OSA mask

Royal Philips Electronics has launched a full-face mask as a minimal-contact alternative for the treatment of obstructive sleep apnoea (OSA). The FullLife mask covers...

EC approves Xolair for children

The EC has approved Xolair (omalizumab) in patients aged six to eleven years, providing a new treatment approach to nearly 35,000 children in the...

Research reveals divided opinion over private sector

MPs expect the private sector to play a greater role in healthcare provision in the future, a recent poll has shown. The survey also...

Public concerned over novel vaccine risks

Parents and healthcare workers may refuse the H1N1 vaccine for themselves or their children due to fears about the risks of a novel vaccine....

DH to consult on Automatic Generic Substitution

The Department of Health (DH) plans to conduct a full, formal consultation on the arrangements for the implementation of Automatic Generic Substitution this Autumn....

Latest articles

image of DNA on blue background to show Junk DNA affects inherited cancer risk

Junk DNA affects inherited cancer risk: New research

A new study published in the British Journal of Cancer shows that inherited cancer risk is not only affected by mutations in key cancer...
Image of map of the world held by two hands on blue background to show Half of WHO-recommended policies to reduce chronic diseases are not put into practice

Half of WHO-recommended policies to reduce chronic diseases are not put into practice

The first analysis of WHO-recommended policies to reduce chronic diseases finds that implementation is slowly improving, but on average just over half get no...
Image of white lungs on green background to show New global survey shows public perceptions of lung cancer

New global survey shows public perceptions of lung cancer

New global survey shows public perceptions of lung cancer and also highlights that people believe that prognoses for the disease are dire, and there...

Popular articles

Image of hands shaking on a blue background to show MSD's new HIV-1 treatment approved for use on the NHS

MSD’s new HIV-1 treatment approved for use on the NHS

MSD's new HIV-1 treatment has been approved for use on the NHS. MSD has announced that its new treatment for HIV-1 infection – doravirine...
Science technology equipment showing Novartis highlights progress in R&D pipeline

Novartis highlights progress in R&D pipeline

Novartis is holding an investor event to provide a comprehensive overview of the company’s progress in advancing its R&D pipeline. Key highlights to be presented...
pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
2019 Rubix cube: uncertainty lead to pharma innovation

Pharma in 2019: Has uncertainty led to pharma innovation and change?

As the year draws to a close, has uncertainty led to pharma innovation and change in 2019? Have we been in a Brexit-related stasis?...

Pharmaceutical direct-to-consumer advertising in Europe

DTCA provides a favourable environment for shared decision-making wherein the patient is aware of the risks and benefits of new drugs. It also addresses...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription